ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

Cancer Control Program Guidelines Developed For Payment Of Patient Costs

December 21, 1973

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

Breast Cancer Survivors Report More Severe Fatigue Than Healthy Women

September 28, 2007

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

March 17, 1978